Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua Davis

Showing results (111-120 of 143) with videos related to

Pageof 15
Sort By:
Trials|July 16, 2020
The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trialJustin T Denholm, Joshua Davis, David Paterson, et al.
Cell Reports. Medicine|May 7, 2026
Taxane chemotherapy promotes response to TIM-3 checkpoint blockade via STING-mediated ER stress and HMGB1 secretionAlexis Onimus, Daiana Celias, Shiun Chang, et al.
Family Practice|February 4, 2017
Antibiotic prescribing for acute otitis media and acute sinusitis: a cross-sectional analysis of the ReCEnT study exploring the habits of early career doctors in family practiceAnthea Dallas, Mieke van Driel, Simon Morgan, et al.
Stem Cells Translational Medicine|May 13, 2022
Maturation Delay of Human GABAergic Neurogenesis in Fragile X Syndrome Pluripotent Stem CellsAi Zhang, Irina Sokolova, Alain Domissy, et al.
The Journal of Trauma and Acute Care Surgery|October 1, 2024
Dedicated Chest Wall Injury Program quality review: How to create and incorporate a quality and safety program for surgical stabilization of rib fracturesV Christian Sanderfer, Joshua Davis, John Green, et al.
Acta Biomaterialia|May 13, 2022
Tunable three-dimensional engineered prostate cancer tissues for in vitro recapitulation of heterogeneous in vivo prostate tumor stiffnessNicole L Habbit, Benjamin Anbiah, Luke Anderson, et al.
Family Medicine and Community Health|June 16, 2023
Influenza presentations and use of neuraminidase inhibitors by Australian general practice registrars: a cross-sectional analysis from the ReCEnT studyChris Moller, Mieke van Driel, Andrew Davey, et al.
Annals of Surgical Oncology|February 22, 2024
Determination of Factors Associated with Upstage in Atypical Ductal Hyperplasia to Identify Low-Risk Patients Where Active Surveillance May be an AlternativeAlexandra J E Greene, Joshua Davis, Jessica Moon, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 8, 2024
TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of randomized clinical trials of nafamostat and camostat mesylateMaría Patricia Hernández-Mitre, Susan C Morpeth, Balasubramanian Venkatesh, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 9, 2024
Erratum to 'TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of randomized clinical trials of nafamostat and camostat mesylate' [Clin Microbiol Infect (30) (2024) 743-754]María Patricia Hernández-Mitre, Susan C Morpeth, Balasubramanian Venkatesh, et al.
Pageof 15

Showing results (111-120 of 143) with videos related to

Sort By:
Pageof 15
Trials|July 16, 2020
The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trialJustin T Denholm, Joshua Davis, David Paterson, et al.
Cell Reports. Medicine|May 7, 2026
Taxane chemotherapy promotes response to TIM-3 checkpoint blockade via STING-mediated ER stress and HMGB1 secretionAlexis Onimus, Daiana Celias, Shiun Chang, et al.
Family Practice|February 4, 2017
Antibiotic prescribing for acute otitis media and acute sinusitis: a cross-sectional analysis of the ReCEnT study exploring the habits of early career doctors in family practiceAnthea Dallas, Mieke van Driel, Simon Morgan, et al.
Stem Cells Translational Medicine|May 13, 2022
Maturation Delay of Human GABAergic Neurogenesis in Fragile X Syndrome Pluripotent Stem CellsAi Zhang, Irina Sokolova, Alain Domissy, et al.
The Journal of Trauma and Acute Care Surgery|October 1, 2024
Dedicated Chest Wall Injury Program quality review: How to create and incorporate a quality and safety program for surgical stabilization of rib fracturesV Christian Sanderfer, Joshua Davis, John Green, et al.
Acta Biomaterialia|May 13, 2022
Tunable three-dimensional engineered prostate cancer tissues for in vitro recapitulation of heterogeneous in vivo prostate tumor stiffnessNicole L Habbit, Benjamin Anbiah, Luke Anderson, et al.
Family Medicine and Community Health|June 16, 2023
Influenza presentations and use of neuraminidase inhibitors by Australian general practice registrars: a cross-sectional analysis from the ReCEnT studyChris Moller, Mieke van Driel, Andrew Davey, et al.
Annals of Surgical Oncology|February 22, 2024
Determination of Factors Associated with Upstage in Atypical Ductal Hyperplasia to Identify Low-Risk Patients Where Active Surveillance May be an AlternativeAlexandra J E Greene, Joshua Davis, Jessica Moon, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 8, 2024
TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of randomized clinical trials of nafamostat and camostat mesylateMaría Patricia Hernández-Mitre, Susan C Morpeth, Balasubramanian Venkatesh, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 9, 2024
Erratum to 'TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of randomized clinical trials of nafamostat and camostat mesylate' [Clin Microbiol Infect (30) (2024) 743-754]María Patricia Hernández-Mitre, Susan C Morpeth, Balasubramanian Venkatesh, et al.
Pageof 15